» Articles » PMID: 1541568

Platelet-activating Factor Modulates Endotoxin-induced Macrophage Procoagulant Activity by a Protein Kinase C-dependent Mechanism

Overview
Journal Infect Immun
Date 1992 Mar 1
PMID 1541568
Citations 2
Authors
Affiliations
Soon will be listed here.
Abstract

Macrophage procoagulant activity is an important mediator of extravascular fibrin deposition at sites of infection and appears to contribute to the pathogenesis of several infectious disease processes. Previous studies have shown that the inflammatory mediator platelet-activating factor was able to prime macrophages for induction of procoagulant activity by bacterial lipopolysaccharide. The present studies were designed to examine the mechanism of this priming effect. Platelet-activating factor (100 nM) primed macrophages for procoagulant activity generation in response to endotoxin at concentrations as low as 100 ng/ml and also following exposure to Escherichia coli, Bacteroides fragilis, and Staphylococcus aureus. The priming effect occurred following a pretreatment with platelet-activating factor for as short as 1 min, suggesting a rapid activation event. Two different doses of the calcium ionophore ionomycin were used to mimic the peak and sustained effects of platelet-activating factor on cytoplasmic calcium levels (1 microM and 100 nM, respectively). Neither dose was able to mimic the priming effect. However, extracellular calcium was necessary for induction of procoagulant activity and the priming effect. By contrast, the protein kinase C agonist phorbol myristate acetate reproduced the priming phenomenon observed for platelet-activating factor. In further support of the concept that protein kinase C activation mediated the effect of platelet-activating factor, the specific protein kinase C inhibitor staurosporine reversed the ability of platelet-activating factor to augment induction of macrophage procoagulant activity by endotoxin. These data suggest mechanisms by which inflammatory mediators within the microenvironment of infection might modulate the host response to bacterial pathogens.

Citing Articles

The nucleocapsid protein of SARS-CoV induces transcription of hfgl2 prothrombinase gene dependent on C/EBP alpha.

Han M, Yan W, Huang Y, Yao H, Wang Z, Xi D J Biochem. 2008; 144(1):51-62.

PMID: 18390877 PMC: 7109852. DOI: 10.1093/jb/mvn042.


The role of tyrosine phosphorylation in lipopolysaccharide- and zymosan-induced procoagulant activity and tissue factor expression in macrophages.

Dackiw A, Grinstein S, Brisseau G, McGilvray I, Nathens A, McGuire J Infect Immun. 1997; 65(6):2362-70.

PMID: 9169775 PMC: 175327. DOI: 10.1128/iai.65.6.2362-2370.1997.

References
1.
Rotstein O, Pruett T, Simmons R . Fibrin in peritonitis. V. Fibrin inhibits phagocytic killing of Escherichia coli by human polymorphonuclear leukocytes. Ann Surg. 1986; 203(4):413-9. PMC: 1251127. DOI: 10.1097/00000658-198604000-00013. View

2.
Abecassis M, Falk J, Makowka L, Dindzans V, Falk R, Levy G . 16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection. J Clin Invest. 1987; 80(3):881-9. PMC: 442316. DOI: 10.1172/JCI113147. View

3.
Almdahl S, Osterud B . Experimental gram-negative peritonitis: decreased thromboplastin activity in organs with a simultaneous rise of thromboplastin in blood monocytes and peritoneal macrophages. Res Exp Med (Berl). 1986; 186(5):317-24. DOI: 10.1007/BF01852097. View

4.
Janco R, Morris P . Regulation of monocyte procoagulant by chemoattractants. Blood. 1985; 65(3):545-52. View

5.
Prydz H, Lyberg T . Effect of some drugs on thromboplastin (factor III) activity of human monocytes in vitro. Biochem Pharmacol. 1980; 29(1):9-14. DOI: 10.1016/0006-2952(80)90236-1. View